Most prostate cancer is slow-growing and treatable. But one type that’s rare is often deadly. Learn about transitional cell or urothelial carcinoma.

Transitional cell cancer of the kidney is rare. But the type of TCC that occurs in the bladder -- transitional cell carcinoma -- is the most common kind of bladder cancer .

Bladder cancer is the ninth most common type of cancer ... Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder. Nature Genetics, 2011; DOI: 10.1038 ...

Bladder cancer: Most commonly transitional cell carcinoma (TCC) and less commonly squamous cell carcinoma, adenocarcinoma, ...

Bladder cancer occurs in 15 50% of patients after the management of upper-tract TCC. ... Management of Patients With Upper Urinary Tract Transitional Cell Carcinoma - Medscape - Aug 01, 2007.

Objective: To determine whether exposure to lawn or garden chemicals was associated with an increased risk of transitional cell carcinoma (TCC) of the urinary bladder in Scottish terriers. Design: ...

Transitional cell carcinoma (TCC) kidney cancer is a type of cancer in the lining of the kidney or the ureters. The ureters are the tubes that carry urine from the kidneys to the bladder.

Purpose: To determine maximum-tolerated dose, toxicities, and pharmacokinetics associated with weekly intravesical gemcitabine therapy in patients with superficial bladder cancer. Patients and Methods ...

Background A 60-year-old female with a 6-month history of muscle-invasive transitional cell carcinoma of the bladder presented with an enlarging subcutaneous lesion involving her right flank. She ...

Bladder cancer occurs due to abnormal cell growth in the urinary bladder. The most common kind usually is urothelial cancer or transitional cell carcinoma. ... Ultrasound, chest X-ray ...

Bladder Cancer Following Upper-tract TCC. ... Cite this: Management of Patients With Upper Urinary Tract Transitional Cell Carcinoma - Medscape - Aug 01, 2007. Summary and Introduction; ...

Intravesical Gemcitabine Therapy for Superficial Transitional Cell Carcinoma of the Bladder: A Phase I and Pharmacokinetic Study. JCO 21 , 697-703 (2003). DOI: 10.1200/JCO.2003.09.028 ...